The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic ...

The following is a summary of “Vancomycin-resistant Enterococcus (VRE) Pneumonia in a Patient With Advanced Chronic ...

For people in the MetroWest region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype Following recent ...

Verona Pharma (VRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram ...

The following is a summary of "Emergent Pericardial Window in a Patient with Sarcoidosis-like Interstitial Lung Disease, COPD ...

Higher frequency and severity of acute exacerbations of COPD increases the risk for myocardial infarction and pulmonary embolism.

While there's currently no cure for multiple sclerosis, a lot of new treatment options have become available—many in just the ...

The FDA has approved Dupixent as an add-on maintenance therapy for adults with inadequately controlled COPD and an eosinophilic phenotype.

Dupixent was approved for treating COPD with raised blood eosinophils in the EU in July 2024. Dupixent was also approved for the COPD indication in China last week. Sanofi’s stock has gained 16.0% so ...

This deal combines Spire's patient monitoring technology with Wellinks' virtual-led cardiopulmonary care approach, creating ...

Two Michigan hospitals had the highest excess readmission ratios for heart attack patients in the U.S. between July 1, 2019, and June 30, 2022, according to CMS data released July 31.